Background Chronic pulmonary aspergillosis (CPA) can complicate underlying pulmonary
diseases, and clinical management of CPA is challenging. Guidelines support clinicians but …

Chronic pulmonary aspergillosis (CPA) is a challenging respiratory infection caused by the
environmental fungus Aspergillus. CPA has a poor prognosis, with reported 1-year mortality …

Background Though invasive pulmonary aspergillosis is a well known complication of
COVID‐19 pneumonia, indolent forms of aspergillosis have been rarely described. Methods …

Abstract Purpose of Review Inhaled antifungals achieve high lung concentrations with
minimal systemic adverse events. Despite being available for over five decades, data …

The diagnosis of chronic pulmonary aspergillosis (CPA) is established by combined clinic-
radio-microbiological criteria. Out of the different microbiological criteria, a positive serology …

Aspergilloma, also known as Aspergillus fungus ball or mycetoma, is a rare disease. A
fungal infection is the cause of Chronic Pulmonary Aspergillosis (CPA), a debilitating lung …